MIRM
Mirum Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$91.83
−7.07%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 52.43x
- P/S forward
- 7.97x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -572.13x
- Price / sales
- 9.65x
- Price / cash flow
- -13.08x
Enterprise value
- Enterprise value
- $6.3B
- EV / sales
- 10.17x
- EV / EBITDA
- -8.09x
- EV / EBIT
- -58.38x
- Market cap
- $6.0B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026